Relevance of in vitro SCREENIT results for drug-induced QT interval prolongation in vivo: A database review and analysis

SCREENIT increased the predictability of preclinical results for QTc prolongation without generating any false positive results in class I (13% in class II). Making decisions without isolated heart data increases the risk for eliminating efficient drugs displaying hERG inhibition.